Psychiatry and Neurology, Epilepsy · Spokane, WA
NPI
1326308339
Since 2012
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
8
Medicare group memberships
Hospitals
5
Hospital affiliations
105 W 8th Ave Ste 318c
Spokane, WA, 99204
Phone (509) 474-6650
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
1,233 services
Medicare patients, 2024
596
Average age 71
Drug cost, 2024
$1.8M
3,199 prescriptions
Company payments, 2025
$199
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natasha G Sparrow was code 95720 (neurologic), 176 times for 105 patients. In total Natasha G Sparrow billed 1,233 services in 28 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 176 | 105 | $158.76 | $28K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 167 | 142 | $12.28 | $2,051 |
| 99214 Office E&M - Established | Office | 119 | 96 | $75.57 | $8,993 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 94 | 51 | $25.05 | $2,354 |
| 95717 Neurologic | Facility | 91 | 85 | $82.05 | $7,466 |
| 95813 Neurologic | Facility | 78 | 77 | $63.39 | $4,944 |
| 95819 Neurologic | Facility | 74 | 72 | $43.96 | $3,253 |
| 95816 Neurologic | Facility | 71 | 71 | $42.69 | $3,031 |
| 99215 Office E&M - Established | Office | 65 | 56 | $125.56 | $8,162 |
| 99213 Office E&M - Established | Office | 59 | 53 | $55.21 | $3,257 |
| 95819 Neurologic | Office | 51 | 51 | $367.92 | $19K |
| 99205 Office E&M - New | Office | 44 | 44 | $166.10 | $7,308 |
| 95816 Neurologic | Office | 34 | 34 | $313.09 | $11K |
| 95812 Neurologic | Facility | 30 | 30 | $42.40 | $1,272 |
| 95718 Neurologic | Facility | 20 | 20 | $99.60 | $1,992 |
By year: 2022 $81K for 851 services; 2023 $82K for 842 services; 2024 $117K for 1,233 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natasha G Sparrow prescribed most often to Medicare patients was Levetiracetam, with 822 prescriptions and refills. In total Natasha G Sparrow wrote 3,199 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 822 | 1,394 | 161 | $26K |
| Lamotrigine Generic | 519 | 815 | 72 | $15K |
| Lacosamide Generic | 350 | 457 | 50 | $40K |
| Levetiracetam Er Levetiracetam | 177 | 339 | 41 | $18K |
| Zonisamide Generic | 136 | 210 | 20 | $8,149 |
| Clobazam Generic | 127 | 131 | 16 | $11K |
| Topiramate Generic | 123 | 186 | 14 | $1,523 |
| Divalproex Sodium Generic | 91 | 110 | 11 | $7,681 |
| Lamotrigine Er Lamotrigine | 73 | 97 | 13 | $15K |
| Divalproex Sodium Er Divalproex Sodium | 60 | 64 | Under 11 | $2,903 |
| Carbamazepine Er Carbamazepine | 60 | 82 | Under 11 | $4,313 |
| Briviact Brivaracetam | 57 | 57 | Under 11 | $82K |
| Epidiolex Cannabidiol (Cbd) | 50 | 55 | Under 11 | $198K |
| Sertraline Hcl Generic | 38 | 42 | Under 11 | $118 |
| Oxcarbazepine Generic | 37 | 63 | Under 11 | $2,536 |
Brand drugs: 267 claims; generic drugs: 2,903 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natasha G Sparrow $199 ($199 in general payments such as food, travel and fees) from 3 companies. The largest payer was LivaNova USA, Inc. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.